Evidence map›Paper›PMID 39839108›Full record

ArticleFrontiers in microbiology2024

Effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants.

Jun Qiu, Sha Wu, Ruiwen Huang, Zhenyu Liao, Xiongfeng Pan, Kunyan Zhao, Yunlong Peng, Shiting Xiang, Yunhui Cao, Ye Ma and 1 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jun Qiu *The School of Pediatrics, Hengyang Medical School, University of South China, Hunan Children's Hospital, Hengyang, Hunan, China.
Sha Wu *The School of Pediatrics, Hengyang Medical School, University of South China, Hunan Children's Hospital, Hengyang, Hunan, China.
Ruiwen HuangDepartment of Neonatology, Hunan Children's Hospital, Changsha, Hunan, China.
Zhenyu LiaoDepartment of Neonatology, Hunan Children's Hospital, Changsha, Hunan, China.
Xiongfeng PanPediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, Hunan, China.
Kunyan ZhaoPediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, Hunan, China.
Yunlong PengPediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, Hunan, China.
Shiting XiangPediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, Hunan, China.
Yunhui CaoThe School of Pediatrics, Hengyang Medical School, University of South China, Hunan Children's Hospital, Hengyang, Hunan, China.
Ye MaDepartment of Neonatology, Hunan Children's Hospital, Changsha, Hunan, China.
Zhenghui XiaoThe School of Pediatrics, Hengyang Medical School, University of South China, Hunan Children's Hospital, Hengyang, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Antibiotics, as the most commonly prescribed class of drugs in neonatal intensive care units, have an important impact on the developing neonatal gut microbiota. Therefore, comprehending the effects of commonly used antibiotic therapy on the gut microbiota and butyrate-producers in early infants could provide information for therapeutic decision-making in the NICU. Objectives: To explore the effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants. Methods: A total of 72 infants were included in the study. We performed 16S rRNA sequencing on stool swab samples collected from neonatal intensive care unit patients who received amoxicillin-clavulanic acid (AC, Results: Our study showed that there were significant differences in Shannon index ( Conclusion: We found that antibiotic therapy had an adverse impact on the initial development of gut microbiota and leaded to a reduction in the abundance of butyrate-producers, particularly

Indexed as

amoxicillin-clavulanic acidantibioticsbutyrate-producersgut microbiotamoxalactam

Identifiers

PMID39839108
PMCPMC11748296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.